Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Receivables - Net (2016 - 2025)

Historic Receivables - Net for BioCorRx (BICX) over the last 16 years, with Q3 2025 value amounting to $194442.0.

  • BioCorRx's Receivables - Net fell 3810.93% to $194442.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $194442.0, marking a year-over-year decrease of 3810.93%. This contributed to the annual value of $76266.0 for FY2023, which is 4140.24% down from last year.
  • Per BioCorRx's latest filing, its Receivables - Net stood at $194442.0 for Q3 2025, which was down 3810.93% from $51242.0 recorded in Q2 2025.
  • BioCorRx's 5-year Receivables - Net high stood at $314170.0 for Q3 2024, and its period low was $12215.0 during Q3 2023.
  • In the last 5 years, BioCorRx's Receivables - Net had a median value of $101177.5 in 2021 and averaged $113265.8.
  • Per our database at Business Quant, BioCorRx's Receivables - Net tumbled by 8770.57% in 2023 and then skyrocketed by 247200.16% in 2024.
  • BioCorRx's Receivables - Net (Quarter) stood at $56359.0 in 2021, then soared by 130.93% to $130152.0 in 2022, then plummeted by 41.4% to $76266.0 in 2023, then soared by 311.94% to $314170.0 in 2024, then plummeted by 38.11% to $194442.0 in 2025.
  • Its last three reported values are $194442.0 in Q3 2025, $51242.0 for Q2 2025, and $153360.0 during Q1 2025.